Site-specific phosphorylation regulates human T-cell leukemia virus type 2 Rex function in vivo

Journal of Virology

Volumn 83, Issue 17, 2009, Pages 8859-8868

  Kesic, Matthew ^a   Ward, Michael ^c   Semmes, O John ^c   Green, Patrick L ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; PROTEIN P26; REGULATOR PROTEIN; REX PROTEIN; SERINE; THREONINE; UNCLASSIFIED DRUG; VIRUS ANTIGEN; REX PROTEIN, HUMAN T LYMPHOTROPIC VIRUS 2; REX PROTEIN, HUMAN T-LYMPHOTROPIC VIRUS 2;

AFFINITY PURIFICATION; ARTICLE; CELL COMPARTMENTALIZATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE MAPPING; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 2; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; MAMMAL CELL; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; PURIFICATION; REGULATORY MECHANISM; SITE DIRECTED MUTAGENESIS; TANDEM MASS SPECTROMETRY; AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; BIOLOGICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; CYTOPLASM; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; PHYSIOLOGY;

HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; MAMMALIA;

AMINO ACID SEQUENCE; CELL NUCLEUS; CHROMATOGRAPHY, AFFINITY; CYTOPLASM; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, REX; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; SERINE; TANDEM MASS SPECTROMETRY; THREONINE;

EID: 69249205589     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00908-09     Document Type: Article

References (58)

1. Adachi, Y., T. D. Copeland, C. Takahashi, T. Nosaka, A. Ahmed, S. Oroszlan, and M. Hatanaka. 1992. Phosphorylation of the Rex protein of human T-cell leukemia virus type I. J. Biol. Chem. 267:21977-21981.
2. Adachi, Y., T. Nosaka, and M. Hatanaka. 1990. Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I (HTLV-I). Biochem. Biophys. Res. Commun. 169:469-475.
3. Askjaer, P., and J. Kjems. 1998. Mapping of miltiple RNA binding sites of the human T-cell lymphotropic virus type 1 Rex protein with 5′- and 3′-Rex response elements. J. Biol. Chem. 273:11463-11471.
4. Bogerd, H., and W. C. Greene. 1993. Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo. J. Virol. 67:2496-2502. (Pubitemid 23118843)
5. Bogerd, H. P., G. L. Huckaby, Y. F. Ahmed, S. M. Hanly, and W. C. Greene. 1991. The type 1 human T-cell leukemia virus (HTLV-I) Rex trans-activator binds directly to the HTLV-I Rex and the type 1 human immunodeficiency virus Rev RNA response elements. Proc. Natl. Acad. Sci. USA 88:5704-5708.
6. Boxus, M., J. C. Twizere, S. Legros, J. F. Dewulf, R. Kettmann, and L. Willems. 2008. The HTLV-1 Tax interactome. Retrovirology 5:76.
7. Cann, A. J., J. D. Rosenblatt, W. Wachsman, N. P. Shah, and I. S. Y. Chen. 1985. Identification of the gene responsible for human T-cell leukemia virus transcriptional regulation. Nature 318:571-574. (Pubitemid 16173046)
8. Crenshaw, D. G., J. Yang, A. R. Means, and S. Kornbluth. 1998. The mitotic peptidyl-prolyl isomerase, Pin1, interacts with Cdc25 and Plx1. EMBO J. 17:1315-1327.
9. Durkin, S. S., M. D. Ward, K. A. Fryrear, and O. J. Semmes. 2006. Site-specific phosphorylation differentiates active from inactive forms of the human T-cell leukemia virus type 1 Tax oncoprotein. J. Biol. Chem. 281:31705-31712.
10. Felber, B. K., H. Paskalis, C. Kleinman-Ewing, F. Wong-Staal, and G. N. Pavlakis. 1985. The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. Science 229:675-679.
11. Feuer, G., and P. L. Green. 2005. Comparative biology of human T-cell lynphotropic virus type 1 (HTLV-1) and HTLV-2. Oncogene 24:5996-6004. (Pubitemid 43086117)
12. 0 arrest. Biochem. Biophys. Res. Commun. 265:658-663.
13. Gatza, M. L., J. C. Watt, and S. Marriott. 2003. Cellular transformation by the HTLV-I Tax protein, a jack-of-all-trades. Oncogene 22:5141-5149.
14. Grant, C., K. Barmak, T. Alefantis, J. Yao, S. Jacobson, and B. Wigdahl. 2002. Human T cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation. J. Cell Physiol. 190:133-159. (Pubitemid 34027818)
15. Green, P. L., and I. S. Y. Chen. 2001. Human T-cell leukemia virus types 1 and 2, p. 1941-1969. In D. M. Knipe, P. Howley, D. Griffin, R. Lamb, M. Martin, and S. Straus (ed.), Virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
16. Green, P. L., Y. Xie, and I. S. Y. Chen. 1991. The Rex proteins of human T-cell leukemia virus type II differ by serine phosphorylation. J. Virol. 65: 546-550.
17. Green, P. L., M. T. Yip, Y. Xie, and I. S. Y. Chen. 1992. Phosphorylation regulates RNA binding by the human T-cell leukemia virus Rex protein. J. Virol. 66:4325-4330.
18. Hammes, S. R., and W. C. Green. 1993. Multiple arginine residues within the basic domian of HTLV-1 Rex are required for specific RNA binding and function. Virology 193:41-49. (Pubitemid 23192776)
19. Hidaka, M., J. Inoue, M. Yoshida, and M. Seiki. 1988. Post transcriptional regulator (rex) of HTLV-I initiates expression of viral structural proteins but suppresses expression of regulatory proteins. EMBO J. 7:519-523.
20. Hjelle, B., O. Appenzeller, R. Mills, S. Alexander, N. Torrez-Martinez, R. Jahnke, and G. Ross. 1992. Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 339:645-646.
21. Hope, T. J., B. L. Bond, B. McDonald, N. P. Klein, and T. G. Parslow. 1991. Effector domains of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex are functionally interchangeable and share an essential peptide motif. J. Virol. 65:6001-6007.
22. Jones, K. S., K. Fugo, C. Petrow-Sadowski, Y. Huang, D. C. Bertolette, I. Lisinski, S. W. Cushman, S. Jacobson, and F. W. Ruscetti. 2006. Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells. J. Virol. 80:8291-8302.
23. + T cells. J. Virol. 79:12692-12702.
24. Joseph, J. D., E. S. Yeh, K. I. Swenson, A. R. Means, and Winkler. 2003. The peptidyl-prolyl isomerase Pin1. Prog. Cell Cycle Res. 5:477-487.
25. Kim, J. S., and R. T. Raines. 1993. Ribonuclease S-peptide as a carrier in fusion proteins. Protein Sci. 2:348-356.
26. Kusuhara, K., M. Anderson, S. M. Pettiford, and P. L. Green. 1999. Human T-cell leukemia virus type 2 Rex protein increases stability and promotes nuclear to cytoplasmic transport of gag/pol and env RNAs. J. Virol. 73:8112-8119. (Pubitemid 29441671)
27. Lairmore, M., and G. Franchini. 2007. Human T-cell leukemia virus types 1 and 2, p. 2071-2106. In B. Fields, D. Knipe, P. Howley, R. Chanock, T. Monath, J. Melnick, B. Roizman, and S. Straus (ed.), Fields virology, vol.5. Lippincott Williams, and Wilkins, Philadelphia, PA.
28. Loyet, K. M., J. T. Stults, and D. Arnott. 2005. Mass spectrometric contributions to the practice of phosphorylation site mapping through 2003: a literature review. Mol. Cell Proteomics 4:235-245.
29. Lu, K. P., and X. Z. Zhou. 2007. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat. Rev. Mol. Cell Biol. 8:904-916.
30. Mulloy, J. C., T. Kislyakova, A. Cereseto, L. Casareto, A. LoMonico, J. Fullen, M. V. Lorenzi, A. Cara, C. Nicot, C. Giam, and G. Franchini. 1998. Human T-cell lymphotropic/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB/ATF functional domain. J. Virol. 72:8852-8860.
31. Narayan, M., K. Kusuhara, and P. L. Green. 2001. Phosphorylation of two serine residues regulates human T-cell leukemia virus type 2 Rex function. J. Virol. 75:8440-8448. (Pubitemid 32768948)
32. Narayan, M., I. Younis, D. M. D'Agostino, and P. L. Green. 2003. Functional domain structure of human T-cell leukemia virus type 2 Rex. J. Virol. 77:12829-12840. (Pubitemid 37430677)
33. Ohta, M., H. Nyunoya, H. Tanako, T. Okamoto, T. Akagi, and K. Shimotohno. 1988. Identification of a cis-regulatory element involved in accumulation of human T-cell leukemia virus type II genomic mRNA. J. Virol. 62:4445-4449.
34. Palmeri, D., and M. H. Malim. 1996. The human T-cell leukemia virus type 1 posttranscriptional trans-activator Rex contains a nuclear export signal. J. Virol. 70:6442-6445. (Pubitemid 26266870)
35. Ramadan, E., M. Ward, X. Guo, S. S. Durkin, A. Sawyer, M. Vilela, C. Osgood, A. Pothen, and O. J. Semmes. 2008. Physical and in silico approaches identify DNA-PK in a Tax DNA-damage response interactome. Retrovirology 5:92.
36. Ressler, S., G. F. Morris, and S. J. Marriott. 1997. Human T-cell leukemia virus type 1 Tax transactivates the human proliferating cell nuclear antigen promoter. J. Virol. 71:1181-1190. (Pubitemid 27030290)
37. Rimsky, L., M. Duc Dodon, E. P. Dixon, and W. C. Greene. 1989. trans-dominant inactivation of HTLV-I and HIV-1 gene expression by mutation of the HTLV-I Rex transactivator. Nature 341:453-456.
38. + T-lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. J. Virol. 73:4856-4865.
39. Rosenblatt, J. D., J. C. Gasson, J. Glaspy, et al. 1987. Relationship between HTLV-II and atypical hairy-cell leukemia: a serologic study of hairy-cell leukemia patients. Leukemia 1:397-401.
40. Rosenblatt, J. D., D. W. Golde, W. Wachsman, A. Jacobs, G. Schmidt, S. Quan, J. C. Gasson, and I. S. Y. Chen. 1986. A second HTLV-II isolate associated with atypical hairy-cell leukemia. N. Engl. J. Med. 315:372-377.
41. Ross, T. M., M. Narayan, Z. Y. Fang, A. C. Minella, and P. L. Green. 2000. Tax transactivation of both NFκB and CREB/ATF is essential for Human T-cell leukemia virus type 2-mediated transformation of primary human cells. J. Virol. 74:2655-2662.
42. Ross, T. M., S. M. Pettiford, and P. L. Green. 1996. The tax gene of human T-cell leukemia virus type 2 is essential for transformation of human T lymphocytes. J. Virol. 70:5194-5202.
43. 1- to S-phase transition in human lymphocytes by the human T-cell leukemia/lymphotropic virus type 1 Tax protein. J. Virol. 72:633-640.
44. Shen, M., P. T. Stukenberg, M. W. Kirschner, and K. P. Lu. 1998. The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins. Genes Dev. 12:706-720.
45. Siomi, H., H. Shida, S. H. Nam, T. Nosaka, M. Maki, and M. Hatanaka. 1988. Sequence requirements for nucleolar localization of human T cell leukemia virus type I pX protein, which regulates viral RNA processing. Cell 55:197-209. (Pubitemid 18256759)
46. Stukenberg, P. T., and M. W. Kirschner. 2001. Pin1 acts catalytically to promote a conformational change in Cdc25. Mol. Cell 7:1071-1083.
47. Tootle, T. L., and I. Rebay. 2005. Post-translational modifications influence transcription factor activity: a view from the ETS superfamily. Bioessays 27:285-298.
48. Toyoshima, H., M. Itoh, J.-I. Inoue, M. Seiki, F. Takaku, and M. Yoshida. 1990. Secondary structure of the human T-cell leukemia virus type I Rex-responsive element is essential for Rex regulation of RNA processing and transport of unspliced RNAs. J. Virol. 64:2825-2832. (Pubitemid 20171272)
49. Voss, O. H., S. Batra, S. J. Kolattukudy, M. E. Gonzalez-Mejia, J. B. Smith, and A. I. Doseff. 2007. Binding of caspase-3 prodomain to heat shock protein 27 regulates monocyte apoptosis by inhibiting caspase-3 proteolytic activation. J. Biol. Chem. 282:25088-25099.
50. Watanabe, T. 1997. HTLV-1-associated diseases. Int. J. Hematol. 66:257-278.
51. Weichselbraun, I., G. K. Farrington, J. R. Rusche, E. Bohnlein, and J. Hauber. 1992. Definition of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type 1 Rex protein activation domain by functional exchange. J. Virol. 66:2583-2587.
52. Whitmarsh, A. J., and R. J. Davis. 2000. Regulation of transcription factor function by phosphorylation. Cell Mol. Life Sci. 57:1172-1183.
53. Xie, L., and P. L. Green. 2005. Envelope is a major viral determinant of the distinct in vitro cellular transformation tropism of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2. J. Virol. 79:14536-14545. (Pubitemid 41636252)
54. Xie, L., M. Kesic, B. Yamamoto, M. Li, I. Younis, M. D. Lairmore, and P. L. Green. 2009. HTLV-2 Rex carboxy terminus is an inhibitory/stability domain that regulates Rex functional activity and viral replication. J. Virol. 83:5232-5243.
55. Ye, J., L. Xie, and P. L. Green. 2003. Tax and overlapping Rex sequences do not confer the distinct transformation tropisms of HTLV-1 and HTLV-2. J. Virol. 77:7728-7735.
56. Yip, M. T., W. S. Dynan, P. L. Green, A. C. Black, S. J. Arrigo, A. Torbati, S. Heaphy, C. Ruland, J. D. Rosenblatt, and I. S. Y. Chen. 1991. HTLV-II Rex protein binds specifically to RNA sequences of the HTLV LTR but poorly to the HIV 1 RRE. J. Virol. 65:2261-2272.
57. Yoshida, M. 2005. Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis. Oncogene 24:5931-5937. (Pubitemid 43086111)
58. You, H., H. Zheng, S. A. Murray, Q. Yu, T. Uchida, D. Fan, and Z. X. Xiao. 2002. IGF-1 induces Pin1 expression in promoting cell cycle S-phase entry. J. Cell Biochem. 84:211-216. (Pubitemid 34033279)